Nonpharmacologic therapy for hypertension: Does it really work?

Current Cardiology Reports

Volumn 8, Issue 6, 2006, Pages 418-424

  Tejada, Thor ^b   Fornoni, Alessia ^b   Lenz, Oliver ^b   Materson, Barry J ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ALCOHOL CONSUMPTION; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIET THERAPY; DISEASE COURSE; EXERCISE; FEEDBACK SYSTEM; HUMAN; HYPERTENSION; LIFESTYLE; MEDITATION; MOTIVATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW; RISK REDUCTION; SMOKING CESSATION; SODIUM RESTRICTION; WEIGHT REDUCTION;

ALCOHOL DRINKING; DIET, SODIUM-RESTRICTED; EXERCISE; HUMANS; HYPERTENSION; POTASSIUM, DIETARY; SMOKING CESSATION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 33750993168     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0099-6     Document Type: Review

References (50)

1. Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
2. Hall JE, Jones DW, Kuo JJ, et al.: Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003, 5:386-392.
3. Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988, 297:319-328.
4. Flegal KM, Carroll MD, Ogden CL, et al.: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
5. National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. Obes Res 1998, 6(Suppl 2):51S-209S.
6. Dornfeld LP, Maxwell MH, Waks A, et al.: Mechanisms of hypertension in obesity. Kidney Int 1987, 22:S254-S258.
7. Neter JE, Stam BE, Kok FJ, et al.: Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003, 42:878-884.
8. The Trials of Hypertension Prevention Collaborative Research Group: Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. Arch Intern Med 1997, 157:657-667.
9. Dansinger ML, Gleason JA, Griffith JL, et al.: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005, 293:43-53.
10. Kruger J, Galuska DA, Serdula MK, et al.: Physical activity profiles of U.S. adults trying to lose weight: NHIS 1998. Med Sci Sports Exerc 2005, 37:364-368.
11. Dowda M, Ainsworth BE, Addy CL, et al.: Correlates of physical activity among U.S. young adults, 18 to 30 years of age, from NHANES III. Ann Behav Med 2003, 26:15-23.
12. Cohen MD, D'Amico FJ, Merenstein JH: Weight reduction in obese hypertensive patients. Fam Med 1991, 23:25-28.
13. Curioni CC, Lourenco PM: Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond) 2005, 29:1168-1174.
14. Tanaka H, Dinenno FA, Monahan KD, et al.: Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000, 102:1270-1275.
15. Brown MD, Moore GE, Korytkowski MT, et al.: Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women. Hypertension 1997, 30:1549-1553.
16. Scheuer J, Tipton CM: Cardiovascular adaptations to physical training. Annu Rev Physiol 1977, 39:221-251.
17. Kelley GA, Kelley KS: Progressive resistance exercise and resting blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2000, 35:838-843.
18. He FJ, MacGregor GA: Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens 2002, 16:761-770.
19. Dickinson HO, Mason JM, Nicolson DJ, et al.: Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006, 24:215-233.
20. Appel LJ, Champagne CM, Harsha DW, et al.: Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003, 289:2083-2093.
21. Sacks FM, Svetkey LP, Vollmer WM, et al.: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001, 344:3-10.
22. Geleijnse JM, Hofman A, Witteman JC, et al.: Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997, 29:913-917.
23. Appel LJ, Espeland MA, Easter L, et al.: Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001, 161:685-693.
24. Chobanian AV, Hill M: National Heart, Lung, and Blood Institute workshop on sodium and blood pressure: a critical review of current scientific evidence. Hypertension 2000, 35:858-863.
25. He FJ, Markandu ND, MacGregor GA: Modest salt reduction lowers blood pressure in isolated systolic hypertension and combined hypertension. Hypertension 2005, 46:66-70.
26. Kawasaki T, Delea CS, Bartter FC, et al.: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978, 64:193-198.
27. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996, 27:481-490.
28. Burnier M, Bochud M, Maillard M: Proximal tubular function and salt sensitivity. Curr Hypertens Rep 2006, 8:8-15.
29. Hamlyn JM, Blaustein MP, Bova S, et al.: Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991, 88:6259-6263.
30. Obarzanek E, Proschan MA, Vollmer WM, et al.: Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension 2003, 42:459-467.
31. Cohn JN, Kowey PR, Whelton PK, et al.: New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med 2000, 160:2429-2436.
32. Whelton PK, He J, Cutler JA, et al.: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997, 277:1624-1632.
33. Appel LJ, Brands MW, Daniels SR, et al.: Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006, 47:296-308.
34. Morris RC, Jr., Sebastian A, Forman A, et al.: Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999, 33:18-23.
35. Chalmers J, Morgan T, Doyle A, et al.: Australian National Health and Medical Research Council dietary salt study in mild hypertension. J Hypertens Suppl 1986, 4:S629-637.
36. Khaw KT, Barrett- Connor E: Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 1987, 316:235-240.
37. Klatsky AL, Friedman GD, Siegelaub AB, et al.: Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med 1977, 296:1194-1200.
38. Xin X, He J, Frontini MG, et al.: Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2001, 38:1112-1117.
39. Annual smoking-attributable mortality, years of potential life lost, and economic costs--United States, 1995-1999. MMWR Morb Mortal Wkly Rep 2002, 51:300-303.
40. Omvik P: How smoking affects blood pressure. Blood Press 1996, 5:71-77.
41. Cryer PE, Haymond MW, Santiago JV, et al.: Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976, 295:573-577.
42. Jaimes EA, DeMaster EG, Tian RX, et al.: Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 2004, 24:1031-1036.
43. Jonas MA, Oates JA, Ockene JK, et al.: Statement on smoking and cardiovascular disease for health rare professionals. American Heart Association. Circulation 1992, 86:1664-1669.
44. Mann SJ, James GD, Wang RS, et al.: Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA 1991, 265:2226-2228.
45. Minami J, Ishimitsu T, Matsuoka H: Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999, 33:586-590.
46. LaCroix AZ, Lang J, Scherr P, et al.: Smoking and mortality among older men and women in three communities. N Engl J Med 1991, 324:1619-1625.
47. Henningfield JE, Fant RV, Buchhalter AR, et al.: Pharmacotherapy for nicotine dependence. CA Cancer J Clin 2005, 55:281-299.
48. Elliott WJ, Izzo JL, White WB, et al.: Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens 2004, 6:553-559.
49. Giles TL, Lasserson TJ, Smith BJ, et al.: Continuous positive pressure for obstructive sleep apnea in adults. Cochrane Database Syst Rev 2006, 1:CD001106.
50. Rakic V, Burke V, Beilin LJ: Effects of coffee on ambulatory blood pressure in older men and women. A randomized controlled trial. Hypertension 1999, 33:869-873.